EUVIMEDEUVIMED entdecken
Open Access

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

Moshe Phillip iD, Peter Achenbach iD, Ananta Addala iD, Anastasia Albanese-O'Neill iD, Tadej Battelino iD, Kirstine J Bell iD, Rachel E J Besser iD, Ezio Bonifacio iD, Helen M Colhoun iD, Jennifer J Couper iD, Maria E Craig iD, Thomas Danne iD und 48 weitere

Diabetes Care · 24.06.2024

DOI: 10.2337/dci24-0042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 24.06.2024. Verfasst von Moshe Phillip und 59 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Autoantibodies, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 54-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease progression, type 1 diabetes screening programs are being increasingly emphasized. Once broadly implemented, screening initiatives will identify significant numbers of islet autoantibody–positive (IAb+) children and adults who are at risk for (confirmed single IAb+) or living with (multiple IAb+) early-stage (stage 1 and stage 2) type 1 diabetes. These individuals will need monitoring for disease progression; much of this care will happen in nonspecialized settings. To inform this monitoring, JDRF, in conjunction with international experts and societies, developed consensus guidance. Broad advice from this guidance includes the following: 1) partnerships should be fostered between endocrinologists and primary care providers to care for people who are IAb+; 2) when people who are IAb+ are initially identified, there is a need for confirmation using a second sample; 3) single IAb+ individuals are at lower risk of progression than multiple IAb+ individuals; 4) individuals with early-stage type 1 diabetes should have periodic medical monitoring, including regular assessments of glucose levels, regular education about symptoms of diabetes and DKA, and psychosocial support; 5) interested people with stage 2 type 1 diabetes should be offered trial participation or approved therapies; and 6) all health professionals involved in monitoring and care of individuals with type 1 diabetes have a responsibility to provide education. The guidance also emphasizes significant unmet needs for further research on early-stage type 1 diabetes to increase the rigor of future recommendations and inform clinical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesDiabetes Mellitus, Type 1HumansIslets of Langerhans

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Forschergruppe Diabetes, Technical University Munich, Klinikum Rechts Der Isar, Munich, Germany.
  • Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, CA.

ORCID-Profile: Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino, Kirstine J Bell, Rachel E J Besser, Ezio Bonifacio, Helen M Colhoun, Jennifer J Couper, Maria E Craig, Thomas Danne, Carine de Beaufort, Klemen Dovc, Kimberly A Driscoll, Sanjoy Dutta, Osagie Ebekozien, Helena Elding Larsson, Daniel J Feiten, Robert A Gabbay, Mary P Gallagher, Carla J Greenbaum, Kurt J Griffin, Michael J Haller, Christel Hendrieckx, Emile Hendriks, Richard I G Holt, Heba M Ismail, Laura M Jacobsen, Suzanne B Johnson, Leslie E Kolb, Olga Kordonouri, Karin Lange, Robert W Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M Maahs, M Loredana Marcovecchio, Chantal Mathieu, Holly K O'Donnell, Tal Oron, Shivajirao P Patil, Rodica Pop-Busui, Marian J Rewers, Stephen S Rich, Desmond A Schatz, Rifka Schulman-Rosenbaum, Kimber M Simmons, Emily K Sims, Jay S Skyler, Laura B Smith, Cate Speake, Andrea K Steck, Nicholas P B Thomas, Ksenia N Tonyushkina

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Phillip, M., Achenbach, P., Addala, A., Albanese-O'Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E., Colhoun, H. M., Couper, J. J., Craig, M. E., Danne, T., de Beaufort, C., Dovc, K., Driscoll, K. A., Dutta, S., Ebekozien, O., Elding Larsson, H., Feiten, D. J., …, & Tonyushkina, K. N. (2024). Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care. https://doi.org/10.2337/dci24-0042

Vancouver

Phillip M, Achenbach P, Addala A, Albanese-O'Neill A, Battelino T, Bell KJ, et al. Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care. 2024. doi:10.2337/dci24-0042

BibTeX
@article{Phillip2024,
  author = {Phillip, Moshe and Achenbach, Peter and Addala, Ananta and Albanese-O'Neill, Anastasia and Battelino, Tadej and Bell, Kirstine J and Besser, Rachel E J and Bonifacio, Ezio and Colhoun, Helen M and Couper, Jennifer J and Craig, Maria E and Danne, Thomas and de Beaufort, Carine and Dovc, Klemen and Driscoll, Kimberly A and Dutta, Sanjoy and Ebekozien, Osagie and Elding Larsson, Helena and Feiten, Daniel J and Frohnert, Brigitte I and Gabbay, Robert A and Gallagher, Mary P and Greenbaum, Carla J and Griffin, Kurt J and Hagopian, William and Haller, Michael J and Hendrieckx, Christel and Hendriks, Emile and Holt, Richard I G and Hughes, Lucille and Ismail, Heba M and Jacobsen, Laura M and Johnson, Suzanne B and Kolb, Leslie E and Kordonouri, Olga and Lange, Karin and Lash, Robert W and Lernmark, Åke and Libman, Ingrid and Lundgren, Markus and Maahs, David M and Marcovecchio, M Loredana and Mathieu, Chantal and Miller, Kellee M and O'Donnell, Holly K and Oron, Tal and Patil, Shivajirao P and Pop-Busui, Rodica and Rewers, Marian J and Rich, Stephen S and Schatz, Desmond A and Schulman-Rosenbaum, Rifka and Simmons, Kimber M and Sims, Emily K and Skyler, Jay S and Smith, Laura B and Speake, Cate and Steck, Andrea K and Thomas, Nicholas P B and Tonyushkina, Ksenia N},
  title = {Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes},
  journal = {Diabetes Care},
  year = {2024},
  doi = {10.2337/dci24-0042}
}
Kostenlos starten →